Literature DB >> 31386363

Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease.

Masayoshi Miyagawa1, Toshiyuki Akiyama1, Yoshiyuki Taoda1, Kenji Takaya1, Chika Takahashi-Kageyama1, Kenji Tomita1, Kazuya Yasuo1, Kazunari Hattori1, Shinya Shano1, Ryu Yoshida1, Takao Shishido1, Tomokazu Yoshinaga1, Akihiko Sato1, Makoto Kawai1.   

Abstract

The medicinal chemistry and structure-activity relationships (SAR) for a novel series of carbamoyl pyridone bicycle (CAB) compounds as influenza Cap-dependent endonuclease (CEN) inhibitors are disclosed. Substituent effects were evaluated at the C (N)-1, N-3, and C-7 positions of the CAB ring system using a docking study. Submicromolar EC50 values were achieved in the cellular assay with C-7-unsubstituted CAB which possessed a benzhydryl group on either the C-1 or the N-1 position. An N-3 substituent was found to be critical for the plasma protein binding effect in vitro, and the CAB-N analogue 2v exhibited reasonable total clearance (CLtot). More importantly, compound 2v displayed significant efficacy in a mouse model infected with influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31386363     DOI: 10.1021/acs.jmedchem.9b00861

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Identification of cap-dependent endonuclease inhibitors with broad-spectrum activity against bunyaviruses.

Authors:  Shinsuke Toba; Akihiko Sato; Makoto Kawai; Yoshiyuki Taoda; Yuto Unoh; Shinji Kusakabe; Haruaki Nobori; Shota Uehara; Kentaro Uemura; Keiichi Taniguchi; Masanori Kobayashi; Takeshi Noshi; Ryu Yoshida; Akira Naito; Takao Shishido; Junki Maruyama; Slobodan Paessler; Michael J Carr; William W Hall; Kumiko Yoshimatsu; Jiro Arikawa; Keita Matsuno; Yoshihiro Sakoda; Michihito Sasaki; Yasuko Orba; Hirofumi Sawa; Hiroshi Kida
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.